Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Trans Genic Inc. (2342) Stock Price & Analysis

2342 Stock Chart & Stats

¥211.00-¥4.00(-1.86%)
At close: 3:30 PM GMT+9
¥220¥240¥2603 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 212.00 - JPY 216.00
52-Week Range
JPY 182.00 - JPY 487.00
Previous Close
JPY 214.00
Volume
N/A
Average Volume (3M)
24.48K
Market Cap
JPY 3.63B
Enterprise Value
JPY 3.90B
Total Cash (Recent Filing)
JPY 2.13B
Total Debt (Recent Filing)
JPY 2.09B
Price to Earnings (P/E)
112.1
Beta
1.31
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Mar 28, 2024
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improved Operating Profitability

Returning to positive EBIT and EBITDA in 2026 marks a meaningful operating improvement after the 2025 downturn. If maintained, better operating profitability can strengthen internal funding capacity and provide a more durable base for investment, although consistency remains important.

Moderate Leverage

Debt-to-equity of roughly 0.28–0.54 and improvement in 2026 indicate moderate leverage rather than an acute balance-sheet burden. Sizable equity relative to assets provides a cushion that can support resilience and preserve strategic flexibility while profitability stabilizes.

Operating Cash Flow Recovery

Operating cash flow improved from deeply negative levels in 2023–2024 to slightly positive in 2025–2026. This recovery is a constructive foundation for liquidity and could reduce funding pressure if it develops into sustained, materially positive cash generation.

Bears Say

Recurring Net Losses

Recurring net losses and highly volatile profitability weaken earnings quality and make the company’s economic performance difficult to assess with confidence. The recent operating improvement has not yet translated into consistently positive bottom-line results, limiting dependable internal capital generation.

Revenue Instability

Inconsistent revenue performance, including a large decline in 2026, raises concern about demand stability and the durability of the company’s operating recovery. Weaker or uneven top-line growth can reduce operating leverage and make future margin improvement harder to sustain.

Persistent Free Cash Flow Burn

Negative free cash flow across 2023–2026 indicates that the business has not consistently funded investment and operations from internally generated cash. Continued cash burn can increase reliance on external funding and constrain strategic flexibility if operating cash flow does not strengthen materially.

2342 FAQ

What was Trans Genic Inc.’s price range in the past 12 months?
Trans Genic Inc. lowest stock price was ¥182.00 and its highest was ¥487.00 in the past 12 months.
What is Trans Genic Inc.’s market cap?
Trans Genic Inc.’s market cap is ¥3.63B.
When is Trans Genic Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Trans Genic Inc.’s earnings last quarter?
Trans Genic Inc. released its earnings results on Aug 12, 2026. The company reported ¥8.17 earnings per share for the quarter.
Is Trans Genic Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Trans Genic Inc. pay dividends?
Trans Genic Inc. pays a Annually dividend of ¥3 which represents an annual dividend yield of ―. See more information on Trans Genic Inc. dividends here
What is Trans Genic Inc.’s EPS estimate?
Trans Genic Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trans Genic Inc. have?
Trans Genic Inc. has 16,999,142 shares outstanding.
What happened to Trans Genic Inc.’s price movement after its last earnings report?
Trans Genic Inc. reported an EPS of ¥8.17 in its last earnings report. Following the earnings report the stock price went up 4.525%.
Which hedge fund is a major shareholder of Trans Genic Inc.?
Currently, no hedge funds are holding shares in JP:2342
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology